Synthetic PEGylated glycoproteins and their utility in gene delivery.

PEGylated glycoproteins (PGPs) were synthesized by copolymerizing a Cys-terminated PEG-peptide, glycopeptide, and melittin peptide. Compositionally unique PGPs were prepared by varying the ratio of PEG-peptide (20-90%) and melittin (0-70%) with a constant amount of glycopeptide (10%). The PGPs were purified by RP-HPLC, and characterized for molecular weight and polydispersity by GPC-HPLC and SDS-PAGE and for composition by RP-HPLC following reduction to form monomeric peptides. PGPs formed DNA condensates of 200-300 nm in diameter that were administered to mice via the tail vein. Biodistribution studies confirmed their primary targeting to liver hepatocytes with a DNA metabolic half-life of 1 h. Upon stimulation by hydrodynamic dosing with saline, PGP DNA (5 microg) mediated luciferase expression in the liver detected by bioluminescence imaging (BLI) after 24 h. The level of gene expression mediated by PGP DNA was 5000-fold less than direct hydrodynamic dosing of an equivalent amount of DNA and was independent of the mol percent of melittin incorporated into the polymer, but dependent on the presence of galactose on PGP. The results establish the ability to prepare three-component gene delivery polymers that function in vivo. Further design improvements in fusogenic peptides for gene delivery and for the simultaneous use of a nuclear targeting strategy will be necessary to approach levels of expression mediated by the direct hydrodynamic dosing of DNA.

[1]  Y. Lee.  Biochemistry of carbohydrate‐protein interaction 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  H. Lodish,et al.  Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. , 1982, The Journal of biological chemistry.

[3]  S. W. Kim,et al.  Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. , 1998, Bioconjugate chemistry.

[4]  K. Rice,et al.  Peptide-mediated gene delivery: influence of peptide structure on gene expression. , 1997, Bioconjugate chemistry.

[5]  T. Bettinger,et al.  Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. , 1999, Bioconjugate chemistry.

[6]  C H Wu,et al.  Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. , 1988, Biochemistry.

[7]  Tae Gwan Park,et al.  PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[8]  C. Tung,et al.  Synthetic Glycopeptide-Based Delivery Systems for Systemic Gene Targeting to Hepatocytes , 2000, Pharmaceutical Research.

[9]  K. Ulbrich,et al.  Polymer‐coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction , 2004, The journal of gene medicine.

[10]  K. Rice,et al.  A Potent New Class of Reductively Activated Peptide Gene Delivery Agents* , 2000, The Journal of Biological Chemistry.

[11]  A. Bolognesi,et al.  Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells , 1984, The Journal of cell biology.

[12]  K Mechtler,et al.  The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. , 1994, The Journal of biological chemistry.

[13]  M. Ogris,et al.  Melittin Enables Efficient Vesicular Escape and Enhanced Nuclear Access of Nonviral Gene Delivery Vectors* , 2001, The Journal of Biological Chemistry.

[14]  Zhi Ding,et al.  Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. , 2003, International journal of pharmaceutics.

[15]  D. Stolz,et al.  Hydroporation as the mechanism of hydrodynamic delivery , 2004, Gene Therapy.

[16]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[17]  L. Seymour,et al.  Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo , 2001, Gene Therapy.

[18]  T. Hirayama,et al.  Chain Length of Cationic α-Helical Peptide Sufficient for Gene Delivery into Cells , 1999 .

[19]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[20]  M. Monsigny,et al.  Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. , 1995, Bioconjugate chemistry.

[21]  K. Rice,et al.  Synthesis of homogeneous glycopeptides and their utility as DNA condensing agents. , 1999, Carbohydrate research.

[22]  T. V. van Berkel,et al.  Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytesin Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.

[23]  K. Rice,et al.  Targeted gene delivery with a low molecular weight glycopeptide carrier. , 1995, Bioconjugate chemistry.

[24]  T. Park,et al.  A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[25]  K. Rice,et al.  Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates. , 2000, Journal of pharmaceutical sciences.

[26]  Ji-seon Kim,et al.  Gene transfer with poly-melittin peptides. , 2006, Bioconjugate chemistry.

[27]  Y. Liu,et al.  Cross-linked low molecular weight glycopeptide-mediated gene delivery: relationship between DNA metabolic stability and the level of transient gene expression in vivo. , 2001, Journal of pharmaceutical sciences.

[28]  F. Szoka,et al.  Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes. , 1999, Human gene therapy.

[29]  M. Monsigny,et al.  Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. , 1993, Nucleic acids research.

[30]  M. Hashida,et al.  Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system , 2000, Gene Therapy.

[31]  K. Rice,et al.  Synthesis of sulfhydryl cross-linking poly(ethylene glycol)-peptides and glycopeptides as carriers for gene delivery. , 2002, Bioconjugate chemistry.

[32]  C. Wu,et al.  Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.

[33]  Sabine Boeckle,et al.  C‐ versus N‐terminally linked melittin‐polyethylenimine conjugates: the site of linkage strongly influences activity of DNA polyplexes , 2005, The journal of gene medicine.

[34]  K. Zatloukal,et al.  Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Briand,et al.  Intracellular rate-limiting steps of gene transfer using glycosylated polylysines in cystic fibrosis airway epithelial cells , 2002, Gene Therapy.

[36]  K. Rice,et al.  In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates. , 2003, Journal of pharmaceutical sciences.

[37]  K. Rice,et al.  Iodinated plasmid DNA as a tool for studying gene delivery. , 1998, Analytical biochemistry.

[38]  E. Smiley,et al.  Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. , 2000, Bioconjugate chemistry.

[39]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[40]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[41]  L. Seymour,et al.  Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors. , 2002, Journal of the American Chemical Society.

[42]  D. Jans,et al.  Using nuclear targeting signals to enhance non‐viral gene transfer , 2002, Immunology and cell biology.

[43]  M. Monsigny,et al.  Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages. , 1996, Human gene therapy.

[44]  Kevin G Rice,et al.  Quantitative bioluminescence imaging of transgene expression in vivo. , 2006, Analytical biochemistry.